Cryo Cell International (CCEL) Enterprise Value (2010 - 2026)

Cryo Cell International (CCEL) has reported Enterprise Value for 17 consecutive years, with -$3.2 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Enterprise Value rose 28.64% year-over-year to -$3.2 million; the TTM figure through May 2026 stood at -$3.2 million (up 28.64% YoY), while the FY2025 annual figure was -$3.3 million, up 5.72% from the prior year.
• Enterprise Value eased to -$3.2 million in Q2 2026 per CCEL's latest filing, from -$2.9 million in the prior quarter.
• Across five years, Enterprise Value topped out at -$979593.0 in Q1 2024 and bottomed at -$4.4 million in Q2 2025.
• Historically, Enterprise Value has averaged -$2.5 million across 5 years, with a median of -$2.7 million in 2022.
• Annual changes were most pronounced in 2022 — Enterprise Value soared 79.35% — and 2024, when it slumped 256.66%.
• Cryo Cell International's Enterprise Value stood at -$1.7 million in 2022, then soared by 43.06% to -$980250.0 in 2023, then plunged by 256.66% to -$3.5 million in 2024, then climbed by 5.72% to -$3.3 million in 2025, then grew by 4.07% to -$3.2 million in 2026.
• Business Quant data shows CCEL's Enterprise Value at -$3.2 million in Q2 2026, -$2.9 million in Q1 2026, and -$3.3 million in Q4 2025.